| Name | KCC2 blocker 1 | 
|---|
| Description | KCC2 blocker 1 is an orally active and selective K+-Cl- cotransporter KCC2 blocker with an IC50 of 1 μM. KCC2 blocker 1 is a benzyl prolinate and has antiepileptic effect[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 IC50: 1 μM (KCC2)[1]  | 
                        
| In Vitro | KCC2 blocker 1 (compound 13; 100 μM) inhibits NKCC1 with 35%. | 
| In Vivo | KCC2 blocker 1 (compound 13; 1 mg/kg iv and 6 mg/kg po) has a t1/2 of 0.3 hours, a CL of 26 mL/min/kg, a C max of 457 ng/mL and a AUC of 726 ng•h/mL for male Wistar rats[1]. Animal Model: Male Wistar rats[1] Dosage: 1 mg/kg or 6 mg/kg (Pharmacokinetic Analysis) Administration: IV (1 mg/kg) and PO (6 mg/kg) Result: Had a t1/2 of 0.3 hours, a CL of 26 mL/min/kg, a C max of 457 ng/mL and a AUC of 726 ng•h/mL. | 
| References | 
| Molecular Formula | C22H25NO5S | 
|---|---|
| Molecular Weight | 415.50 | 
| Storage condition | -20°C |